INTEGRA LIFESCIENCES HOLDINGS CORP Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for repurchase of common stock for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for repurchase of common stock for the quarter ending 2025-09-30 was $0.00.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for repurchase of common stock for the quarter ending 2024-12-31 was $2.47M.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for repurchase of common stock for the quarter ending 2024-09-30 was $0.00, a 100.00% decline year-over-year.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for repurchase of common stock for fiscal 2025 was $221.00K, a 99.58% decline from fiscal 2024.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for repurchase of common stock for fiscal 2024 was $52.47M, a 80.92% decline from fiscal 2023.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for repurchase of common stock for fiscal 2023 was $275.00M, a 120.00% increase from fiscal 2022.
- INTEGRA LIFESCIENCES HOLDINGS CORP payments for repurchase of common stock for fiscal 2022 was $125.00M.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $221.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | |
| 2024-12-31 | $2.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $52.47M 10-K · filed 2026-02-26 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-10-30 | $50.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $50.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-31 | $175.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-06 | $125.00M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $275.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | $125.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04 | $275.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-07-29 | $150.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2023-03-31 | $150.00M 10-Q · filed 2024-05-06 | $150.00M derived: sum of 4 quarters · filed 2025-02-25 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $125.00M 10-K · filed 2025-02-25 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-10-25 | $125.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-27 | $125.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $125.00M 10-Q · filed 2023-04-26 | $125.00M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $0.00 10-K · filed 2024-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-10-26 | $0.00 derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-07-27 | $0.00 derived: sum of 4 quarters · filed 2023-02-22 |
| 2021-03-31 | $0.00 10-Q · filed 2022-04-27 | $0.00 derived: sum of 4 quarters · filed 2023-02-22 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-22 | $100.00M 10-K · filed 2023-02-22 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $100.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-29 | $100.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $100.00M 10-Q · filed 2021-04-29 | $100.00M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $0.00 10-K · filed 2022-02-24 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | |
| 2018-12-31 | $0.00 10-K · filed 2021-02-23 | |
| 2013-12-31 | $0.00 8-K · filed 2014-06-20 | |
| 2012-12-31 | $0.00 derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $0.00 8-K · filed 2014-06-20 |
| 2011-12-31 | $14.45M derived: 8-K 12 month − 10-Q 9 month · filed 2014-06-20 | $83.46M 8-K · filed 2014-06-20 |
| 2011-09-30 | $12.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-10-24 | $69.01M derived: sum of 4 quarters · filed 2013-02-26 |
| 2011-06-30 | $52.69M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-07-31 | |
| 2011-03-31 | $4.32M 10-Q · filed 2012-04-26 | |
| 2010-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-26 | $31.28M 10-K · filed 2013-02-26 |
| 2009-12-31 | $0.00 10-K · filed 2011-02-24 | |
| 2008-12-31 | $0.00 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |